Skip to main content

Case Study: Medical Device Vision System - MES Integration

Submitted by Craig on

TL;DR Summary

$25K AI vision POC failed production requirements but prevented $150K+ pilot investment. Implemented human-centered Andon solution instead. Smart failure methodology: think big, start small, fail fast, scale what works.

Executive Summary

Industry

Dental Products Manufacturing (Medical Device OEM)

Company Profile

$300M revenue, 1,500 employees, FDA-regulated environment

Challenge

FDA date-stamp verification requiring costly dual signatures at every changeover

Solution Tested

AI-assisted vision system with neural network and JSON integration over OPC-UA to MES

Investment

$25,000 POC budget over 3 months

Outcome

Strategic failure that validated human-centered approach

Alternative Solution

Andon cord system reducing changeover verification time

Key Learning

Sometimes people remain the optimal solution - fail fast, scale what works

The Manufacturing Challenge

Regulatory Compliance Reality

A leading dental products manufacturer faced a costly compliance bottleneck that was consuming 2 hours of production time daily. FDA regulations required visible and indelible date stamps on primary containers - specifically, custom 5-digit expiry dates capturing the chemistry lifecycle inside each syringe.

Baseline Process Metrics

  • 4 changeovers per day requiring dual verification
  • 30 minutes average changeover time per event
  • 2 hours daily spent on signature acquisition
  • 100% manual process - operator plus supervisor wet ink signatures
  • Zero automation - paper batch records only

The company's continuous improvement culture drove exploration of electronic verification systems that could potentially eliminate the dual-signature requirement while maintaining or exceeding human accuracy levels.

The Innovation Opportunity

Traditional quality management systems in FDA-regulated environments rely heavily on human verification. However, the repetitive nature of date-stamp verification presented an apparent opportunity for computer vision automation.

"We needed to prove whether AI could reliably distinguish between similar digits under magnification while meeting FDA traceability requirements," explains the project stakeholder.

The AI Vision Solution Architecture

Image
Vision System to MES with OPC-UA

 

Technical Implementation Design

The proof-of-concept centered on a specialized vision system designed to integrate seamlessly with existing manufacturing execution systems (MES):

  1. Specialized lightbox with controlled lighting conditions
  2. Local camera system for high-resolution image capture
  3. Neural network processing trained on production samples
  4. JSON integration over OPC-UA with MES for date code verification
  5. Pass/fail feedback loop to control manufacturing workflow

Integration Architecture

AI Vision System Component Specifications

Component

Specification

Purpose

Camera System

High-resolution with specialized lightbox

Controlled image capture environment

Neural Network

Local processing, trained on 500 samples

Date stamp character recognition

MES Integration

JSON data exchange protocol over OPC-UA

Expiry date generation and verification

Workflow Control

Pass/fail signal to manufacturing line

Automated process control

Training and Validation Methodology

The neural network training approach focused on real-world operational conditions:

  • 500 syringe samples representing 125 days of operational variation
  • Multiple lighting conditions to simulate production environment
  • Various stamping pressures and ink consistency levels
  • Different operators and shift conditions included

Implementation Process

POC Execution Framework

The project followed a disciplined approach designed to minimize risk while maximizing learning:

POC Investment Breakdown

Total Budget

$25,000 allocated across 3 months

Hardware

Specialized camera and lightbox equipment

Software

Neural network development and training platform

Engineering Time

Integration development and testing resources

Risk Mitigation

Limited scope prevented larger pilot investment

Success Criteria Definition

Clear metrics were established before POC initiation:

  1. Zero false positives - no good parts incorrectly rejected
  2. Minimal false negatives - acceptable miss rate for defective stamps
  3. Integration feasibility - seamless MES connectivity
  4. Speed requirements - match or exceed human verification time

Results and Critical Analysis

The Technical Reality

Laboratory testing revealed both the promise and limitations of the AI vision approach:

POC Performance Results

Metric

Target

Achieved

Assessment

False Positives

0%

0%

✓ Target Met

False Negatives

<5%

Too High

✗ Failed Criteria

Integration

Seamless

Functional

✓ Technical Success

Processing Speed

<30 seconds

15 seconds

✓ Performance Exceeded

Root Cause Analysis

The excessive false negative rate stemmed from fundamental challenges in the production environment:

Critical Failure Points Identified

  • Lighting variations - Production conditions differed from laboratory setup
  • Magnification challenges - Similar digits difficult to distinguish consistently
  • Stamp quality variations - Ink consistency and pressure differences
  • Training data limitations - 500 samples insufficient for production variation

Despite technical feasibility, the system couldn't achieve the reliability required for FDA-regulated manufacturing where quality escapes carry significant risk.

The Strategic Pivot

Alternative Solution Implementation

Rather than proceeding to a costly pilot phase, the team implemented a human-centered approach:

"Sometimes the best technology solution is recognizing when people remain the optimal answer. The Andon cord approach preserved human expertise while addressing our speed concerns."

Andon Cord System Benefits

  • Faster supervisor response - reduced changeover verification time
  • Preserved human judgment - maintained quality expertise
  • Cost-effective implementation - minimal technology investment
  • Better operational fit - aligned with existing workflows

Financial Impact Comparison

Solution Cost-Benefit Analysis

Approach

Implementation Cost

Risk Level

Time to Value

Outcome

AI Vision Pilot

$150,000+ estimated

High

9-12 months

Avoided

AI Vision POC

$25,000

Low

3 months

Learning achieved

Andon System

<$5,000

Minimal

4 weeks

Implemented

Lessons Learned and Strategic Framework

Craig's Innovation Methodology Validated

This case study perfectly demonstrates the value of disciplined experimentation in manufacturing environments:

"Think Big, Start Small, Fail Fast, Scale What Works"

  1. Think Big - Envisioned fully automated quality verification eliminating dual signatures
  2. Start Small - Limited investment to $25,000 POC over 3 months
  3. Fail Fast - Recognized technical limitations within POC timeframe
  4. Scale What Works - Implemented human-centered Andon solution instead

Risk Management Excellence

The POC structure prevented a common industry failure pattern. Research shows that 88% of AI pilots fail to reach production, often after significant investment. This case avoided that trap through:

  • Clear success criteria established before technical work began
  • Limited financial exposure through POC-first approach
  • Stakeholder expectation management - failure positioned as learning
  • Alternative solution readiness - Andon approach developed in parallel

Organizational Culture Impact

"The failure was perceived as part of the cost of continuous improvement. This cultural acceptance of intelligent failure is crucial for innovation in regulated industries."

Industry Implications for Medical Device Manufacturers

When AI Isn't the Answer

This case provides valuable guidance for medical device manufacturers evaluating computer vision solutions:

Environmental Complexity Factors

  • FDA-regulated environments require extremely low error rates
  • Production lighting variations challenge laboratory-trained models
  • Human expertise value often underestimated in automation planning
  • Integration complexity can exceed technical feasibility challenges

Smart Technology Evaluation Criteria

AI Readiness Assessment Framework

Factor

High AI Potential

Human-Centered Approach

Task Complexity

Repetitive, rule-based

Judgment-intensive, variable

Error Tolerance

Some false positives acceptable

Zero tolerance for escapes

Environment

Controlled conditions

Variable production settings

Training Data

Abundant, representative

Limited, high variation

Strategic Technology Planning

This POC informed the company's broader digital transformation strategy:

  • AI evaluation capability - internal expertise developed for future assessments
  • Risk management framework - POC-first approach standardized
  • Vendor relationship building - technology partnerships established
  • Innovation culture strengthening - intelligent failure celebrated

Conclusion: The Value of Intelligent Failure

While the AI vision system failed to meet production requirements, the POC delivered exceptional value through risk mitigation and strategic learning. The $25,000 investment prevented a potential $150,000+ pilot failure while accelerating implementation of an effective human-centered solution.

Final Project Outcomes

Financial Impact

$125,000+ avoided through prevented pilot investment

Timeline Benefit

6-9 months saved by avoiding failed pilot phase

Operational Improvement

Andon system reduced changeover verification time

Strategic Learning

Framework established for future AI evaluations

Cultural Development

Innovation mindset strengthened through intelligent failure

For medical device manufacturers facing similar automation decisions, this case demonstrates that smart experimentation methodology often delivers more value than successful technology implementation. The key is building organizational capability to fail fast, learn quickly, and scale what actually works - whether that's AI or enhanced human processes.

"POCs and pilots are all part of the experimentation lifecycle. The goal isn't always to prove the technology works - sometimes the greatest value comes from proving it doesn't, before you invest too much to change course."